Author:
Reinisch Walter,Gottlieb Klaus,Colombel Jean-Frederic,Danese Silvio,Panaccione Remo,Panes Julian,Peyrin-Biroulet Laurent,Rubin David,Sands Bruce E.,Schreiber Stefan,Vermeire Severine,Mulberg Andrew,Sandborn Bill
Subject
Gastroenterology,Hepatology
Reference19 articles.
1. Ulcerative colitis: clinical trial endpoints guidance for industry. Draft guidance. Report no. 15028dft.doc 07/27/16 UCM515143,2016
2. European Medicines Agency. Guideline on the development of new medicinal products for the treatment of Ulcerative Colitis. CHMP/EWP/18463/2006 Rev.1. Available from: https://www.ema.europa.eu/documents/scientific-guideline/guideline-development-new-medicinal-products-treatment-ulcerative-colitis-revision-1_en.pdf. Accessed June 28, 2018.
3. Development of an index to define overall disease severity in IBD;Siegel;Gut,2018
4. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis;Dignass;J Crohn's Colitis,2012
5. A critical assessment of composite and coprimary endpoints: a complex problem;Buzney;J Am Acad Dermatol,2008
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献